Metastatic Melanoma MEK Inhibitor + BRAF Inhibitor Combo Extends Survival, Reduces Toxicity
Oncology Times, October 2012For patients with metastatic melanoma, adding a MEK inhibitor to a BRAF inhibitor lowered the odds of progression or death by 61 percent at 12 months, compared with use of a BRAF-inhibitor alone, according to the results of a Phase II study reported here at the European Society for Medical Oncology Congress and published simultaneously online in the New England Journal of Medicine
Pressure Ulcers in the Pediatric Population
Journal of the Dermatology Nurses' Association, September/October 2012Pressure ulcer prevention in the pediatric patient is accomplished through pressure ulcer awareness with education to all healthcare providers and families involved in the care of a pediatric patient. Review skin facts, pressure ulcer classification, prevention strategies and more by reading this article.
What’s Your Diagnosis?
Journal of the Dermatology Nurses' Association, October 2012A 76-year-old white woman presented to the dermatology clinic for a 4-month history of nontender nodules on her scalp. She reported that new lesions were appearing over time, with the first lesion occurring on the vertex of her scalp. Sort through potential diagnoses by exploring this article.